Clindamycin is classified as a Category B medication by the FDA, which means that animal reproduction studies have not demonstrated a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women.
Regarding lactation, small amounts of clindamycin may be excreted into breast milk, but it's generally considered safe to use while breastfeeding. However, as with any medication, it's essential to consult with your healthcare provider before taking clindamycin during pregnancy or while breastfeeding to weigh the potential benefits against any potential risks. Your healthcare provider can provide personalized advice based on your specific situation and medical history.
Pregnancy Category B ( by FDA )
Category A (AU TGA )
FDA (United States):
- Clindamycin is classified as Pregnancy Category B by the FDA. This means that animal reproduction studies have not shown a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women. However, the potential benefits of the medication may warrant its use in pregnant women despite potential risks.
TGA (Australia):
- In Australia, medications are classified differently. Clindamycin is categorized as Category A in pregnancy by the TGA. Category A medications have been taken by a large number of pregnant women and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the fetus.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.